Periscope Capital’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-25,000
| Closed | -$16.4K | – | 236 |
|
|
2024
Q4 | $16.4K | Buy |
+25,000
| New | +$16.4K | 0.01% | 143 |
|
|
2023
Q4 | – | Sell |
-347,994
| Closed | -$3.61M | – | 507 |
|
|
2023
Q3 | $3.61M | Hold |
347,994
| – | – | 0.41% | 88 |
|
|
2023
Q2 | $3.59M | Sell |
347,994
-865,552
| -71% | -$8.94M | 0.28% | 125 |
|
|
2023
Q1 | $12.3M | Buy |
1,213,546
+456,046
| +60% | +$4.62M | 0.57% | 48 |
|
|
2022
Q4 | $7.54M | Buy |
757,500
+158,700
| +27% | +$1.58M | 0.32% | 99 |
|
|
2022
Q3 | $5.84M | Sell |
598,800
-400
| -0.1% | -$3.9K | 0.17% | 243 |
|
|
2022
Q2 | $5.82M | Hold |
599,200
| – | – | 0.16% | 263 |
|
|
2022
Q1 | $5.82M | Hold |
599,200
| – | – | 0.15% | 271 |
|
|
2021
Q4 | $5.8M | Buy |
+599,200
| New | +$5.8M | 0.16% | 264 |
|